T-cell inflammation is prognostic of survival in patients with high-risk neuroblastoma enriched for an adrenergic signature
M. E. Kaufman, O. R. Vayani, K. Moore, A. Chlenski, T. Wu, G. Chaves, S. M. Lee, A. V. Desai, C. He, S. L. Cohn, M. A. Applebaum
The paper identifies T-cell inflammation (TCI) as a prognostic marker in high-risk neuroblastoma, showing improved survival in ADRN tumors but not MES tumors.
bioRxiv · Jun 26, 2023 · PreprintCancer Biology